⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLDI News
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach to Manufacturing
globenewswire.com
CLDI
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach to Manufacturing
globenewswire.com
CLDI
Form 8-K
sec.gov
CLDWW
CLDI
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
globenewswire.com
CLDI
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
globenewswire.com
CLDI
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
globenewswire.com
CLDI
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
globenewswire.com
CLDI
Calidi Biotherapeutics Announces Proposed Public Offering
globenewswire.com
CLDI
Calidi Biotherapeutics Announces Proposed Public Offering
globenewswire.com
CLDI
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
globenewswire.com
CLDI